GUARDANT HEALTH, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
GUARDANT HEALTH, INC. (GH) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $27.71 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-07-30
- GUARDANT HEALTH, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $32.80, a 88.61% increase year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $17.39, a 200.87% increase year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $5.78, a 22.21% decline year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $7.43, a 25.08% increase year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $30.64, a 498.44% increase from fiscal 2024.
- GUARDANT HEALTH, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $5.12, a 35.44% decline from fiscal 2023.
- GUARDANT HEALTH, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $7.93, a 26.07% increase from fiscal 2022.
- GUARDANT HEALTH, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $6.29, a 43.79% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.71 10-Q · filed 2026-07-30 | |||
| 2026-03-31 | $32.80 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $30.64 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $23.67 10-Q · filed 2025-10-29 | |||
| 2025-06-30 | $22.56 10-Q · filed 2025-07-30 | |||
| 2025-03-31 | $17.39 10-Q · filed 2025-04-30 | |||
| 2024-12-31 | $5.12 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $4.47 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | $4.46 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | $5.78 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $7.93 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $7.08 10-Q · filed 2023-11-06 | |||
| 2023-06-30 | $6.89 10-Q · filed 2023-08-03 | |||
| 2023-03-31 | $7.43 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $6.29 10-K · filed 2025-02-20 | |||
| 2022-09-30 | $6.34 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | $6.20 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | $5.94 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $11.19 10-K · filed 2024-02-22 | |||
| 2021-09-30 | $10.93 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | $14.34 10-Q · filed 2021-08-05 | |||
| 2021-03-31 | $15.59 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | $6.59 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $6.23 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | $5.42 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | $6.21 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | $3.87 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $3.72 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | $3.28 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | $3.49 10-Q · filed 2019-05-10 | |||
| 2018-12-31 | $3.09 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $2.98 10-Q · filed 2018-11-19 | |||
| 2016-12-31 | $2.25 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |